It has been suggested that cell damage induced by chemotherapy upregulates the expression of MHC-I or costimulatory molecules (e.g., NKG2D ligands) in tumor cells, sensitizes them to Fas or TRAIL mediated apoptosis [35-42], and renders them susceptible to immune effector cells [3-6]. Here, FAS is linked to neoplasm.